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S U M M A R Y
Background: Due to COVID-19, thousands of healthcare workers have been affected and
have lost their lives in the line of duty. For the protection of healthcare workers, WHO and
CDC have made standard guidelines and requirements for PPE use. N95 masks are amongst
the most readily used PPE by healthcare professionals and it is highly recommended by
OSHA that every make and model of N95 should go through a fit test at least once in a year.
Method: A total of 30 randomly selected healthcare professionals (who were a regular user
of N95 respiratory masks) were subjected to assess in-house (saccharin sodium benzoate)
reagent for use for standard qualitative fit testing in our hospital. Threshold testing with
the in-house reagent at three different concentrations was performed prior to establish
participants’ sensitivity to the reagent. After successful completion of threshold testing,
fit test was performed on participants wearing an N95 mask.
Results: All the participants included in the study passed the sensitivity testing with three
concentrations of the reagents, while it was concluded that the concentration of the in-
house reagent that was well suited for the sensitivity testing was a concentration of 1g/
dl saccharin with 10g/dl sodium benzoate. For fit testing 12g/dl was found to be more
appropriate.
Discussion: Our study provided a low cost solution to ensure safety of healthcare workers
who are regular users of N95 masks following guidelines implemented by OSHA and CDC.
Conclusion: The in-house test solution prepared was found to be equally sensitive to its
commercially available counterpart.
ª 2021 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
After the declaration of COVID-19 as a pandemic, extreme
shortages and disruption of personal protective equipment
* Corresponding author. Address: Department of Pathology and Lab-
oratory Medicine, Aga Khan University Hospital, Karachi, Pakistan.
E-mail address: Humaira.shafaq@aku.edu (H. Shafaq).
Available online at www.sciencedirect.com
Infection Prevention in Practice
journal homepage: www.elsevier .com/locate/ ipip
https://doi.org/10.1016/j.infpip.2021.100116
2590-0889/ª 2021 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Infection Prevention in Practice 3 (2021) 100116
(PPE) have been observed by the healthcare organizations.This
supply demand gap is putting health care workers at risk of
contracting COVID-19 and other infectious diseases. The World
Health Organization (WHO) and Center for Disease Control
(CDC) are emphasising the correct and rational use of PPEfor
healthcare workers dealing with the outbreak [1].
Among all the essentials needed by healthcare professionals
to combat the recent outbreak of COVID-19, N95 masks are
amongst the most readily used PPE (which remove particles
from the air when inhaled through it). They effectively filter out
particles (including viruses and bacteria) measuring as small as
0.3micronswith a success rate of 95%. They significantly reduce
the risk of exposure from airborne particles (from small particle
aerosols to large droplets) [2]. According to The Occupational
Safety and Health Administration (OSHA), it is directed that in
order to protect from exposure; N95 masks should make a tight
seal with a wearers’ face. It is highly recommended by OSHA
that every make, size and model of the respirator should go
through the fit testing at least once a year [3].
Fit testing can be done by two methods, quantitative fit
testing and qualitative fit testing. Quantitative testing is done by
a machine that can evaluate actual amount of leakage into a face
piece. There are three methods of quantitative testing approved
by OSHA. These include generating aerosol, ambient aerosol and
controlled negative pressure. It can be used for any respirator
with a tight-fitting mask [3]. Quantitative fit testing removes the
individual subjectivity and therefore is more robust; however the
machine cost and availability of trained users to ensure proper
use, limits its availability in the resource-limited countries.
Qualitative fit testing, on the other hand, is done by a
method that depends on the individual’s sense of taste or smell
and does not assess the amount of leakage. OSHA approves four
different testing methodologies for qualitative fit testing.
These include reagents containing Isoamyl acetate, Saccharin,
Bittrex and Irritant smoke. Qualitative testing is done using a
commercially prepared fit testing solution of standardized
strength that comes with the fit-testing kits, including plastic
hood and nebulizer (see Figure 1). Although hood and nebu-
lizers are reusable, the availability of fit test solution is quite a
challenge (both from an expense point of view and ease of
availability). Especially when used for fit testing large numbers;
as was experienced during the global H1N1 influenza pandemic
in 2009 [4].With global trade shut down during the early wave of
the COVID-19 pandemic, procurement and shipment delays
resulted in acute shortness of commercial fit test solutions.
Due to the COVID-19 pandemic, the use of PPE has increased
rapidly and therefore the need for fit testing has also surged.It
is highly recommended by the CDC to have proper fit testing for
all N95 respirators used by frontline healthcare workers,
endorsing OSHA guidelines. [5]. Considering concerns about a
shortage of fit-testing kits and test solutions, OSHA encourages
employers to prioritize the use of fit-testing equipment to
protect employees who must use respirators for high-hazard
procedures [3].
In order to overcome this demand, we prepared an in-house
fit test solution in our pharmacy compounding services and
compared the results with the commercially available reagent
to observe any difference in the performance of these
reagents. We conducted fit testing through qualitative meth-
odology, already in practice at our center. Numbers of tests had
to be scaled up for mass-testing all hospital employees using
N95 masks at COVID-19 dedicated units.
The main aim of the study was to test whether there is any
difference in the performance between the in-house prepared
reagent and a commercially available reagent for qualitative fit
testing of N95 masks.
Methods
This was a single-blinded study conducted at the of Aga Khan
University (AKU) main campus, Karachi Pakistan. The partic-
ipants were healthcare workers aged 18 years and were
regular users of N95 respiratory masks (who had previously
been fit tested). More than 800 healthcare workers have been
fit-tested at AKU using 3M FT-30 (bitter) Solution and their
pass and fail tests were reviewed. Assuming the hypothesized
frequency of passing sensitivity test to be 91.7% þ/-10 (3), we
estimated a minimum requirement of 28 participants. For the
fit test: keeping a 2-sided confidence level (1-alpha) of 95% and
Power of 80%, a ratio of those who passed fit-testing by com-
mercial kit to those who failed it at 2:1, and assuming 25% pass
fit-testing with an in-house reagent (out of those who failed by
commercial), and 91% pass fit-testing with in-house reagent out
of those who passed by commercial reagent (3), we required a
minimum of 23 participants.
Thus, 34 randomly selected participants were enrolled.
Enrollment was done on a voluntary basis and no compensation
was given to study participants. Consent forms were adminis-
tered to participants prior to testing. Participants failing to
give consent were excluded from the study. Three different
concentrations of the in-house fit testing solution was com-
pounded in our pharmacy following preparation guidelines
from CDC for in-house preparation of fit test solutions [6].
These solutions were placed in identical clean hospital grade
plastic bottles labeled A, B and C: 1 gm, 8 gm and 12 gm Sodium
benzoate/60 ml Saccharin solution in distilled water. All the
solutions had identical consistency and color. Participants with
a known allergic reaction to the contents of testing solutions
were excluded from the study (common allergies may include
eye and skin irritation). Saccharine and Sodium benzoate are
compounds commonly used in food related items and drugs,
hence they are safe to use.No occupational hazard and tox-
icological information have been reported in material safety
data sheets [7,8]. Participants with facial hair interfering the
N95 seal were excluded from the study. Those who had eaten,
drank any flavored drinks or smoked 30 minutes prior to the
study were also excluded.
Figure 1. Picture of hood and nebulizers used for Fit testing
(commercially procured)
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Testing procedure
All the participants that were enrolled in the study had to go
through two phases of study: threshold or sensitivity testing,
and then the actual fit testing. The sensitivity test determines
the participant’s ability to taste the solution. This was done
using all three concentrations of Saccharine-Sodium benzoate
(in-house reagent). The sensitivity of the taste receptors of the
participant being tested was checked by administering a puff of
the lowest concentration of reagent through a hand-held
nebulizer (provided in the fit-testing kit) while wearing a
hood over their head. The reagent is expected to be sweet
(saccharin) in taste. Each individual was asked if they could
taste the reagent; if not, another puff was administered every
20 seconds till the person could sense the taste of the reagent
or 20 puffs count was complete. Once the sweet taste was
sensed, the person was instructed to remember the taste for
the subsequent Fit-test procedure to follow. After gargle and
rinsing mouth completely the next two concentrations were
tested. Only those who could sense the taste were labelled as
“sensitivity test pass” and furthered to the second part of the
study. The proportion of participants who could sense the taste
for each concentration of the reagents was calculated against
the total number of participants.
The fit testing was performed for all three concentrations
for each participant passing the sensitivity test. Each partic-
ipant had to pass all four steps in order to be considered “Fit
test” passed. The standard four steps of fit-testing procedure
are described below.
Step 1 (at baseline)
The participant being fit-tested had to wear the N95 mask
and seal test it, that is, no air should leak from any of the edges
of the mask when the person exhales and negative pressure
(vacuum) is built when inhaling. A hood was placed over the
person’s head and five puffs of the in-house fit-testing reagent
were administered while the participant was asked to breath
normally for 30 seconds. Participants were instructed to indi-
cate if they could sense the taste they were sensitized with. If
yes, the fit test has failed and they were asked to remove the
mask, rinse mouth, repeat donning and seal test and the fit test
was repeated. Two attempts were completed before declaring
a fit-test failed. Participants who did not sense the reagent
taste proceeded to next step.
Step 2 (with deep breath)
An additional five puffs of reagent were administered and
participants were asked to take deep breaths for 30 seconds. If
they could still not taste the reagent, the participant pro-
ceeded to next step. However, if they did feel the sweet taste,
they were instructed to doff mask, rinse out taste, and repeat
Step 1. Two attempts were made before declaring a “fit test”
fail.
Step 3 (with exercise)
Another five puffs of reagent were administered and par-
ticipants were asked to move their head side to side, up and
down, to bend at the waist, reach up and to the side in
measured movements. Participants were asked to continue
these movements for 30 seconds. If they could still not taste
the reagent, then proceed to Step 4. If participants could sense
the taste, then he/she was asked to doff mask, rinse out taste,
and repeat from Step 1. Attempt twice before declaring “fit
test” failed.
Step 4 (with exertion)
Another 5 puffs of reagent were administered and partic-
ipants were instructed to talk continuously for 30 seconds (a
written passage shown to participants to read out). If they can
still not taste the reagent, then fit test is passed. If they can,
then doff mask, rinse out taste, and repeat from Step 1, to
attempt twice before declaring failed.
Data analysis
A data collection form was developed to record the
responses from each participant and reagents. This information
was entered and analyzed into the Microsoft excel version
2010. Data collection variables included participant fail or pass
status with commercial reagent, fit testing solution code,
sensitivity testing response for each concentration (yes or no),
and number of puffs at which sensitivity was achieved, pass or
fail status of fit test for each concentration. Data is presented
in percentages corresponding to the observations made after
the sensitivity testing of each concentration of the reagents.
Sensitivity, specificity, positive (PPV) and negative predictive
value (NPV) for fit test with each concentration was calculated
against commercial reagent.
Ethical consideration
Consent forms were administered to participants prior to
the conductance of the fit testing. The study began after eth-
ical approval from the ethical review committee of Aga Khan
University, Karachi.
Results
All 34 participants passed the first phase, that is, taste
sensitivity testing with all three concentrations of the in-house
reagent. The average number of puffs administered to achieve
sensitization of taste receptors for each concentration are
given in Table I. Performance of each reagent against the 3M
FT-30 (Bittrex) reagent is also shown as sensitivity, specificity,
PPV and NPV. A high specificity and positive predictive value
denoted a better ability of that concentration to detect failure
of fit. The higher the specificity and PPV, the safer to use that
concentration as reagent for fit testing (see Table I).
Looking at the results of the concentration of in-house
reagent, we found 10 g/dl sodium benzoate in 1gm/dl Sac-
charin most suited for taste sensitivity test while for fit-testing
the reagent with 12 g/dl sodium benzoate was found to be most
suitable as it had the highest positive predictive value and did
not miss any person who is likely to fail fit-test by a NIOSH
approved kit.
Discussion
The main purpose of this study was to assess the efficacy of
homemade solution for qualitative fit testing of N95 respirators
in a healthcare setting. Our findings suggest that an in-house fit
test solution can provide a valuable alternative, with per-
formance comparable to a commercial solution. We tested
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commercial grade saccharine alone in earlier phases of the
study using a published protocol [4]. However, results were not
reproducible. We modified our solution by adding Sodium
Benzoate; a common food preservative to the saccharine sol-
ution that perhaps stabilized the solution, and produced con-
sistent results following CDC guidelines [6]. Multiple solutions
with varying concentrations of sodium benzoate were pre-
pared, of which three concentrations (8, 10 and 12 gm) tested
in the current study were most stable and workable.
All staff tested in this study used a 3M N95 model (NIOSH-
approved with head bands) respirator for fit testing using the
in-house as well as the commercial solution. Using 12 gm/dl
sodium benzoate reagent as test solution we were able to
detect all those who failed fit testing using a commercial sol-
ution; thus reaching the specificity of 100% with no false pos-
itive fit tests (i.e. falsely passed fit test), our benchmark for
final approval of the test solution.
Fit testing using NIOSH approved kits is recognized as a tool
that can ensure protection by assessing fit of a specific respi-
rator model or size. However, due to a global shutdown, the
supply and demand chain for respirators and fit test solutions
has critically affected the functionality of many healthcare
organizations. Health Care providers demand availability of
appropriate PPE (especially fit tested face filtering respirators)
for optimum protection.
To compensate for this global shortfall OSHA temporarily
suspended its mandatory requirement of annual fit test of
respirators for all healthcare workers and instead prioritized it
for staff at highest risk. [9] Our study has practical implications
as it provides the option of an uninterrupted supply of home-
made fit test solution that is comparable to NIOSH approved
kits; thus providing a reliable alternative during a global crises
situation. Initial fit testing is essential to determine if the
respirator properly fits the worker and can provide the
expected level of protection. [4].
Our findings are of value to resource limited countries where
the NIOSH approved kits are either not available or are pro-
hibitively expensive. Resource allocation towards health care
is extremely scarce in low-income and middle-income coun-
tries, which are already overburdened with communicable and
non-communicable diseases. As the COVID-19 pandemic tight-
ens its grip around the world and tough decision need to be
made regarding the allocation of healthcare supplies, [10] our
in-house solution provides a cheaper and reliable alternate to
commercial fit testing solution.
We found our homemade sensitivity and test solution to be
stable at room temperature with a shelf life of 30 days. There
was no obvious crystal formation in the solution, however
crystals developed on the nebulizer nozzle after multiple uses.
Users were instructed to thoroughly wash the nebulizer
chambers and nozzles at the end of sessions. Although in this
study comparative analysis was performed using only one type/
model of N95 respirator in principle, this should be applicable
and useful for all makes and model of N95 respirators. Further
studies using different model and style of N95 are however,
required to make our findings more generalizable.
Conclusions
We successfully evaluated an in-house prepared reagent for
fit-testing. The sensitivity and specificity of in-house fit testing
reagent is comparable to the commercial solution and was
found to be stable at room temperature with a shelf life of 30
days.
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Table I
Performance of three concentrations of homemade reagent for fit testing of N95 masks compared to 3M FT-30 (bitter) reagent on 34
healthcare workers of a tertiary care hospital in Karachi
Composition of reagent Mean no. Of puffs














1 g/dl Saccharin þ
Na benzoate 8 g/dl
5.8 (4.5e7.0) 21/23 (91.3) 7/11 (11.8) 21/25 (84) 7/9 (63.6)
1 g/dl Saccharin þ
Na benzoate 10 g/dl
3.3 (2.7e4.0) 21/23 (91.3) 9/11 (81.8) 21/23 (91.3) 9/11 (81.8)
1 g/dl Saccharin þ
Na benzoate 12 g/dl
2.1 (1.8e2.5) 21/23 (91.3) 11/11 (100) 21/21 (100) 11/13 (84.6)
Note: PPV ¼positive predictive value, NPV: negative predictive value.
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